Top

Reactions Weekly

Published in:

01-12-2020 | Atrioventricular Block | Case report

Azithromycin/hydroxychloroquine/lopinavir/ritonavir

Complete atrioventricular-block, torsades-de-pointes and QT-interval-prolongation following off label use: 2 case reports

Published in: Reactions Weekly | Issue 1/2020

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Russo V, et al. Effect of Triple Combination Therapy With Lopinavir-Ritonavir, Azithromycin, and Hydroxychloroquine on QT Interval and Arrhythmic Risk in Hospitalized COVID-19 Patients. Frontiers in Pharmacology 11: 8 Oct 2020. Available from: URL: http://doi.org/10.3389/fphar.2020.582348

Title: Azithromycin/hydroxychloroquine/lopinavir/ritonavir
Complete atrioventricular-block, torsades-de-pointes and QT-interval-prolongation following off label use: 2 case reports
Publication date: 01-12-2020
Publisher: Springer International Publishing
Keywords: Atrioventricular Block
Azithromycin
Ritonavir
COVID-19
Hydroxychloroquine
Published in: Reactions Weekly / Issue 1/2020
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-020-87508-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Azithromycin/hydroxychloroquine/lopinavir/ritonavir

Complete atrioventricular-block, torsades-de-pointes and QT-interval-prolongation following off label use: 2 case reports

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2020

Trametinib

Benzatropine/clozapine

Cisplatin/pembrolizumab

Sunitinib

Antineoplastics

Prednisolone